The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 15,364 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ABBOTT LABS | COM | 002824100 | 7,682 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 2,884 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 10,094 | 350,000 | SH | Call | SOLE | 350,000 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 1,021 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 3,257 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 376 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 6,624 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 5,842 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 328 | 46,622 | SH | SOLE | 46,622 | 0 | 0 | ||
ALCOBRA LTD | SHS | M2239P109 | 1,050 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 14,070 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 3,715 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 933 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 8,353 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 7,280 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 4,254 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 1,851 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 9,734 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 6,489 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 5,844 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 8,766 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
CELGENE CORP | COM | 151020104 | 12,733 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 9,772 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
CURRENCYSHARES SWISS FRANC T | SWISS FRANC SH | 23129V109 | 4,349 | 46,400 | SH | SOLE | 46,400 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 11,417 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 4,118 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 3,794 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 5,748 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 5,974 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,052 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 6,860 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 2,089 | 129,100 | SH | Call | SOLE | 129,100 | 0 | 0 | |
IMMUNOMEDICS INC | COM | 452907108 | 6,239 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 1,304 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 1,830 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 7,606 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 3,455 | 115,182 | SH | SOLE | 115,182 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 2,812 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LION BIOTECHNOLOGIES INC | COM | 53619R102 | 6,776 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 6,726 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 2,546 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 13,246 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 818 | 172,184 | SH | SOLE | 172,184 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 5,575 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 7,326 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 6,539 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 10,104 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 416 | 86,100 | SH | Call | SOLE | 86,100 | 0 | 0 | |
PERRIGO CO PLC | SHS | G97822103 | 5,826 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 6,140 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
QIAGEN NV | REG SHS | N72482107 | 3,783 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 1,139 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 1,666 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 10,212 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 5,486 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
SEATTLE GENETICS INC | COM | 812578102 | 7,916 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 17,038 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 3,992 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 35,514 | 600,000 | SH | Put | SOLE | 600,000 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 8,208 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | ||
SYNERGY PHARMACEUTICALS DEL | COM NEW | 871639308 | 335 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 2,286 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 734 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 1,548 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
VTV THERAPEUTICS INC | CL A | 918385105 | 966 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 4,022 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,503 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 13,416 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 2,734 | 225,000 | SH | SOLE | 225,000 | 0 | 0 |